Publication Name	World Journal of Hepatology
Manuscript ID	13875
Country	United States

Received	2014-09-05 08:05
Peer-Review Started	2014-09-05 08:52
To Make the First Decision	2014-11-27 12:20
Return for Revision	2014-12-02 14:45
Revised	2015-01-15 04:53
Second Decision	2015-02-10 16:20
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-02-12 14:45
Articles in Press	2015-02-12 14:45
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-04-30 11:06
Publish the Manuscript Online	2015-05-19 17:28

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Hepatocellular carcinoma: From diagnosis to treatment
Manuscript Source	Invited Manuscript
All Author List	Abhijeet Waghray, Arvind R Murali and KV Narayanan Menon
Funding Agency and Grant Number
Corresponding Author	Dr. Abhijeet Waghray, MD, Department of Medicine, MetroHealth Medical Center/Case Western Reserve University, 2500 MetroHealth Drive, Cleveland, OH 44109, United States. awaghray@metrohealth.org
Key Words	Hepatocellular carcinoma; Hepatitis C virus; Liver transplantation; Tumor ablation; Sorafenib
Core Tip	Hepatocellular carcinoma (HCC) is a rising cause of cancer related mortality and viral causes of cirrhosis appear to be a major cause. Surveillance helps to detect early stage disease and treatment options are determined by stage of presentation. Three potentially curative options are radiofrequency ablation, liver transplantation and tumor resection. Emerging therapies such as drug-eluting beads-transarterial chemoembolization or sorafenib will continue to advance treatment options in HCC. The following will provide a concise review of HCC from prevention to treatment.
Publish Date	2015-05-19 17:28
Citation	Waghray A, Murali AR, Menon KVN. Hepatocellular carcinoma: From diagnosis to treatment. World J Hepatol 2015; 7(8): 1020-1029
URL	http://www.wjgnet.com/1948-5182/full/v7/i8/1020.htm
DOI	http://dx.doi.org/10.4254/wjh.v7.i8.1020

Full Article (PDF)	WJH-7-1020.pdf
Full Article (Word)	WJH-7-1020.doc
Manuscript File	13875-Review.docx
Answering Reviewers	13875-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form	13875-Conflict-of-interest statement.pdf
Copyright License Agreement	13875-Copyright assignment.pdf
Peer-review Report	13875-Peer-review(s).pdf
Scientific Misconduct Check	13875-Scientific misconduct check.pdf
Scientific Editor Work List	13875-Scientific editor work list.pdf